134 filings
6-K
LEGN
Legend Biotech Corp
3 Jun 24
Current report (foreign)
4:05pm
6-K
LEGN
Legend Biotech Corp
23 May 24
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
5:00pm
6-K
LEGN
Legend Biotech Corp
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
6-K
LEGN
Legend Biotech Corp
22 Apr 24
Current report (foreign)
1:06pm
6-K
LEGN
Legend Biotech Corp
16 Apr 24
Current report (foreign)
7:29am
6-K
909x8tna7rznkyg
8 Apr 24
Current report (foreign)
7:03am
6-K
coxwk66u8w7itf
29 Mar 24
Current report (foreign)
8:00am
6-K
9ycda7
15 Mar 24
FDA ODAC votes 11 to 0 supporting favorable risk-benefit assessment of CARVYKTI based on results from the Phase 3 CARITUDE-4 study
3:18pm
6-K
3jjrsb96q20qa0fp
13 Mar 24
Current report (foreign)
8:36am
6-K
nqe943i xndnxw15
11 Mar 24
Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
7:52am
6-K
8kbx9t8
23 Feb 24
Current report (foreign)
7:16am
6-K
h1jgs2snr10
23 Jan 24
Legend Biotech Corporation 6-K
9:00am
6-K
c3yjq
23 Jan 24
Legend Biotech Corporation 6-K
7:30am
6-K
ne8s mden
9 Jan 24
Legend Biotech Corporation 6-K
4:01pm
6-K
fbg5upb 5vr71
21 Dec 23
Legend Biotech Corporation 6-K
5:17pm
6-K
51p9jij8id8pihyi1s
21 Dec 23
Current report (foreign)
4:15pm
6-K
imur 5tkg0t9c
11 Dec 23
Legend Biotech Corporation 6-K
7:32pm
6-K
jl6wle5 wr9uk
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
6-K
jm4jocznmi zwc7lw
13 Nov 23
Legend Biotech Corp. 6-K
8:30am
6-K
djvaw zny
17 Oct 23
Legend Biotech Corporation 6-K
8:00am